
Current Price | $7.31 | Mkt Cap | $49.4M |
---|---|---|---|
Open | $7.35 | P/E Ratio | -1.30 |
Prev. Close | $7.42 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $7.27 - $7.48 | Volume | 12,026 |
52-Wk Range | $4.00 - $8.74 | Avg. Daily Vol. | 43,763 |
A development stage company, engaged in the clinical development of the anti-cancer drug phenoxodiol.
Current Price | $7.31 | Mkt Cap | $49.4M |
---|---|---|---|
Open | $7.35 | P/E Ratio | -1.30 |
Prev. Close | $7.42 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $7.27 - $7.48 | Volume | 12,026 |
52-Wk Range | $4.00 - $8.74 | Avg. Daily Vol. | 43,763 |
The best Bull and Bear pitches based on recency and number of recommendations.
Good entry point on short term pull back.
Thanks to a low float after a reverse split, MEI stock is bobbing around like a cork in the ocean. After cutting loose from Novogen and their failed plant flavonoid technology, MEI needed to find a new reason to exist and continue paying inflated… More
Read the most recent pitches from players about MEIP.
Recs
Good entry point on short term pull back.
Recs
People like to take their medication and this Pharma should become an outstanding supplier of their needs and therefore they should not go under, but they should excel. At least i feel that they will. JDE
Recs
With over $70 million in cash as of Q1 end, a market cap of less than $60 million, ample catalysts the rest of the year, and lack of market attention to ME-344 and PWT143, I view MEI Pharma as an attractive stock to buy at current levels.
Find the members with the highest scoring picks in MEIP.
superstar2 (84.39) Score: +333.36
The Score Leader is the player with the highest score across all their picks in MEIP.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
superstar2 | 84.39 | 7/6/2016 |
![]() |
5Y | $1.37 | +436.54% | +103.17% | +333.36 | 0 Comment | |
portefeuille | 98.32 | 1/19/2016 |
![]() |
5Y | $1.34 | +448.51% | +124.12% | +324.39 | 0 Comment | |
tcampbellla | 93.32 | 9/10/2008 |
![]() |
5Y | $16.08 | -54.48% | +254.09% | +308.56 | 1 Comment | |
AgentFlashcool | 63.30 | 10/1/2008 |
![]() |
NS | $9.72 | -24.69% | +278.68% | +303.37 | 0 Comment | |
Ruckwerts | 62.77 | 9/30/2011 |
![]() |
3M | $8.86 | -17.01% | +270.79% | +287.79 | 0 Comment | |
igetmoney2010 | < 20 | 6/10/2008 |
![]() |
NS | $18.00 | -59.33% | +225.11% | +284.44 | 0 Comment | |
soundsound | 91.04 | 4/11/2008 |
![]() |
5Y | $16.20 | -54.81% | +227.58% | +282.39 | 0 Comment | |
joesteinhardt | 24.69 | 4/11/2008 |
![]() |
3M | $15.60 | -53.08% | +227.55% | +280.63 | 0 Comment | |
nicvo | 96.28 | 7/8/2008 |
![]() |
5Y | $10.02 | -26.95% | +249.13% | +276.08 | 0 Comment | |
toorima | 85.39 | 7/9/2008 |
![]() |
3M | $9.42 | -22.29% | +244.22% | +266.51 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.